Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust Awards $2.7M for Alzheimer's Genome-Wide Association Study

NEW YORK (GenomeWeb News) – The UK’s Wellcome Trust said this week that it has awarded £1.3 million ($2.7 million) to support a large genome-wide association study with the goal of understanding the genetic basis of late-onset Alzheimer's disease.
Cardiff University will lead the project, which will analyze DNA samples from 14,000 people -- 6,000 with late-onset Alzheimer's disease and 8,000 controls from the UK and US.
The researchers hope to identify common genetic variations that either increase the risk of late-onset Alzheimer’s or protect patients from developing the disease.
Julie Williams, a professor of neuropsychological genetics at Cardiff University and the principal investigator on the project, said in a statement that it is the “largest genetic study ever to look at Alzheimer's.”

Panos Deloukas’ group at the Wellcome Trust Sanger Institute will perform the genotyping for the study with Illumina’s HumanHap550 Genotyping BeadChips.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.